Navigation Links
Boston Scientific Announces Results For First Quarter Ended March 31, 2009
Date:4/20/2009

performances by our Endoscopy, Urology/Gynecology and Neuromodulation businesses. We further reduced risk by settling additional litigation, pre-paying debt, amending our credit facility, and maintaining financial discipline and strong cash flow."

Net sales for the first quarter of 2009 were $2.010 billion, which included sales from divested businesses of $4 million, as compared to net sales of $2.046 billion for the first quarter of 2008, which included sales from divested businesses of $32 million. Excluding the impact of foreign currency and sales from divested businesses, net sales increased four percent over the prior year.

    Worldwide sales of the Company's CRM products for the first quarter were
    as follows:

    (in millions)          U.S.           International         Worldwide
                   Q1 2009   Q1 2008   Q1 2009   Q1 2008   Q1 2009 Q1 2008
      ICD systems     $312      $274      $132      $137      $444    $411
      Pacemaker
       systems          84        82        61        72       145     154

    Total CRM
     products         $396      $356      $193      $209      $589    $565


    Worldwide sales of the Company's coronary stent systems for the first
    quarter were as follows:

    (in millions)         U.S.            International        Worldwide
                   Q1 2009   Q1 2008   Q1 2009   Q1 2008   Q1 2009 Q1 2008
      Drug-eluting    $246      $218      $199      $210      $445    $428
      Bare-metal        16        26        28        36        44      62

    Total coronary
     stent systems    $262      $244      $227      $246      $489    $490


Reported net loss for the first quarter of 2009 was $13 million, or $0.01 per share. Reported results included acquisition-, divestiture-, litigation-, and restructuring-related net charges; discrete tax items and amortization expense (after-tax) of $302 mil
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... iFitDress.com, one of the most famous dress suppliers in the ... dresses online. At the moment, all the brand new ... According to the company’s senior spokesman, the special offer will ... stock is limited. Those who are thinking of buying cheap ... possible. All its products are delicately made by top designers. ...
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation (JPML) issued ... strokes, heart attacks, and other injuries in men who ... as the transferee judge and ordered what could be ... , As one of his first organizing acts, Judge ... who will move the litigation forward on behalf of ...
(Date:8/1/2014)... University School of Medicine in St. Louis helps explain ... frequently are more harmful than similar tumors in females. ... are diagnosed twice as often in males, who suffer ... as long. , The researchers found that retinoblastoma protein ... significantly less active in male brain cells than in ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Parker Waichman ... rights of victims injured by defective medical devices and ... be recalling its Ethicon surgical power morcellator devices used ... sited concerns involving the spread of cancer associated with ... dated July 31, 2014. , Johnson & Johnson ...
(Date:8/1/2014)... York (PRWEB) August 01, 2014 ... the wake of the 2012 Rejuvenate and ABG ... forward in New Jersey’s Bergen County Superior Court, ... in the proceeding, the Court has issued ... governing any and all hard copy and electronic ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Study reveals one reason brain tumors are more common in men 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 3Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 4Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3
... expanding care and care management,company, BRENTWOOD, Tenn., ... care management for the frail elderly,announced today that ... has been appointed to its board of directors., ... management company focused on,improving the quality of life ...
... The Smart Circle,International, LLC, the nation,s leader in ... Health Associates, Inc.,has put together the first-ever National ... and wellness-based physicians that,see preventative and maintenance care ... States., Thomas Edison once stated, "The doctor ...
... Available in Time for Spring Allergy ... ... Zagat Survey(R) guide, launched today, offers people with,seasonal and year-round allergies an ... and tips on how to manage their,allergy symptoms so they can enjoy ...
... Latest SmartSlide ... ... Board: WGBS), a leading developer of,state-of-the-art gene expression, genotyping, cell biology ... SmartSlide 200,Micro-Incubation System, the latest offering in its SmartSlide product,line. The ...
... Physicians and,Nurses Against Tobacco, Inc., (PANAT) an ... petitioning Pope Benedict,XVI to condemn the production, distribution, ... of State, to declare the Vatican the first ... political, spiritual, and moral leader,to set an example ...
... Cardiac Science,Corporation (Nasdaq: CSCX ), a ... and informatics products, announced that,Mexico,s Instituto de ... Estado (ISSSTE) ordered 282 electrocardiograph systems (ECGs) ... Science history. Instrumentation,Technologies de Mexico, Cardiac Science,s ...
Cached Medicine News:Health News:Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors 2Health News:Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors 3Health News:Smart Circle International, LLC Launches Its National Health and Wellness Network Complimentary 1/2-Hour Massage for Everyone 2Health News:20-City Zagat Survey(R) Guide Spotlights Outdoor Destinations and Offers Allergy Management Tips 2Health News:20-City Zagat Survey(R) Guide Spotlights Outdoor Destinations and Offers Allergy Management Tips 3Health News:WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications 2Health News:WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications 3Health News:WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications 4Health News:WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications 5Health News:WaferGen Launches SmartSlide 200 Micro-Incubation System for Stem Cell Research and Cell Biology Applications 6Health News:Physicians and Nurses Against Tobacco (PANAT) Petition Pope Benedict XVI to Condemn Tobacco Industry, and Tobacco Use, and Declare Vatican First Tobacco- Free Country 2Health News:Cardiac Science Delivers Largest Order of Electrocardiograph Systems in Company History 2Health News:Cardiac Science Delivers Largest Order of Electrocardiograph Systems in Company History 3Health News:Cardiac Science Delivers Largest Order of Electrocardiograph Systems in Company History 4
(Date:7/31/2014)... 31, 2014  According to data released today by ... average monthly Medicare Part D premium is expected to ... was originally projected, the Pharmaceutical Care Management Association (PCMA) ... to be a bright spot in American health care. ... region and using cutting edge, cost-saving tools like pharmacy ...
(Date:7/31/2014)... -- IRIDEX Corporation (Nasdaq: IRIX ) today reported ... June 28, 2014.  , Revenues were $10.6 million ... million in the 2013 second quarter and up sequentially from ... the first six months of 2014 were $20.9 million, up ... last year. , Gross margin for the quarter was ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ), a ... the treatment of autoimmune diseases, asthma and allergic ... the second quarter ended June 30, 2014 and provided ... "In the second quarter, we presented preclinical data ... (ATS) demonstrating three novel mechanisms of action of ...
Breaking Medicine Technology:IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8
... on Monday, December 10, 2007, NEW HAVEN, Conn., ... today announced that preliminary data,from its pivotal Phase II ... acute myelogenous leukemia (AML) would be presented,in a poster ... in,Atlanta, Georgia on Saturday, December 8, 2007., The ...
... 5 Replidyne, Inc.,(Nasdaq: RDYN ) announced today ... participate on the New and Powerful Anti-infectives,panel at the ... take place at 11:00 am ET on Thursday, December ... City., A live audio webcast of the panel ...
Cached Medicine Technology:Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting 2Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting 3
... ready-to-use solutions ideal for a wide range ... prepared with 18 megOhm water, filtered using ... sterile bottles., Reliable - Manufactured according ... lot-to-lot consistency. , High Quality - ...
12% Tryptone, 24% Yeast Extract, 4.0% Glycerol. Supplied with 1 liter of 10x phosphate buffer (0190-1L)....
1.2% Tryptone, 2.4% Yeast Extract, 0.4% Glycerol, with 100ml of 10x Phosphate buffer supplement (0190-01)....
10% Casein digest (NZ amine), 5.0% Sodium Chloride, 5.0% Yeast Extract....
Medicine Products: